StockData
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$148.36−1.16 (-0.78%)

Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%

Merck RotaTeq by Year

RotaTeq (rotavirus live oral pentavalent vaccine) — Worldwide constant-currency (ex-exchange) growth YoY (%) (%)

Merck RotaTeq: -5.0% in FY2025, up 2.0 pts from a year earlier.

Latest, FY2025
-5.0%
Period ended Dec 31, 2025
Change on a year earlier
+2.0 pts
-7.0% in FY2024
History
7 years
Since FY2017
Sources
7
Documents cited below

Where the FY2025 figure comes from

“|| RotaTeq | 228 | 121 | 204 | 119 | 673 | 216 | 163 | 193 | 139 | 711 | -14 | -15 | -5 | -5”

Source: Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗

Reported in Form 8-K Table 3 / 10-K / 10-Q MD&A.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRotaTeq (rotavirus live oral pentavalent vaccine) — Worldwide constant-currency (ex-exchange) growth YoY (%) (%)Year on yearSource
FY2025Dec 31, 2025-5.0%+2.0 ptsForm 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
FY2024Dec 31, 2024-7.0%-6.0 ptsForm 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗
FY2023Dec 31, 2023-1.0%–Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗
FY2020Dec 31, 20201.0%-9.0 ptsForm 8-K (tm213179d2_ex99-1.htm, filed 2021-02-04) ↗
FY2019Dec 31, 201910.0%+4.0 ptsForm 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗
FY2018Dec 31, 20186.0%+1.0 ptsForm 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗
FY2017Dec 31, 20175.0%–Form 8-K (a18-5152_1ex99d1.htm, filed 2018-02-02) ↗

Cite this data

StockData. (2026). Merck RotaTeq (%), annual FY2017–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-rotateq-ww-exfx-yoy

See every metric in the Merck KPI table. Data updated Oct 26, 2026.